Aurinia Pharmaceuticals, Inc. (AUPH)
15.28
-0.56
(-3.54%)
USD |
NASDAQ |
May 15, 16:00
15.26
-0.02
(-0.10%)
After-Hours: 20:00
Aurinia Pharmaceuticals Shareholders Equity (Quarterly) : 567.63M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Xenon Pharmaceuticals, Inc. | 1.338B |
| Edesa Biotech, Inc. | 10.20M |
| ProMIS Neurosciences, Inc. | 60.72M |
| Medicus Pharma Ltd. | 0.9502M |
| Kiniksa Pharmaceuticals International Plc | 605.69M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 724.00M |
| Total Liabilities (Quarterly) | 156.37M |
| Debt to Equity Ratio | 0.1209 |
| Current Ratio | 5.548 |
| Net Debt Paydown Yield | 0.11% |